Posts Tagged ‘FDA’

Perhaps you’ve heard that FDA is moving to update the Nutrition Facts panel with information on added sugars, along with some other changes intended to make it simpler and more relevant to consumers. More than 170,000 people were moved to submit comments on this proposal before the comment period closed on August 1. FDA is still sorting […]

Who knew that more than 80,000 people would care about FDA tobacco rules? Well, it seems that they do. August 8 was the cutoff date for comments on the FDA’s proposal for regulating forms of tobacco and nicotine like cigars, pipes, and e-cigarettes. The total number of comments has already surpassed 80,000. Now it’s up to […]

Regulating two of our vices — nicotine and junk food — winds up being a series of experiments on public health. Some of those experiments are more successful than others, and we seldom know their effects until after the fact — if ever. Right now, we’re in the midst of two of these experiments. E-Cigarettes. Sales of […]

In the competitive marketplace for food, one thing that a food maker can do to bolster sales is add sugar. That’s why a serving of low-fat yogurt can easily have more sugar than a kid’s cereal like Lucky Charms. Yogurt is a great example of a food with a healthy halo that has slowly turned into […]

Medical technology companies seem to be making progress this year, bringing biotech innovations for obesity closer to approval for U.S. availability. It’s been more than a decade since the Lap-Band was first approved for obesity treatment in the U.S. Now four technologies are making progress. Vagal Blockade. EnteroMedics won a mixed, but favorable, review for […]

Orexigen and the rest of the world have been poised for action by the FDA today to approve the drug formerly known as Contrave, a combination of bupropion and naltrexone, for the treatment of obesity. Today, June 11, was the date that FDA was required to render judgement on their resubmitted application, based upon new […]

Novo Nordisk has been busy presenting pivotal clinical trial data for their diabetes drug — liraglutide — in the treatment of obesity. Both at the American Association of Clinical Endocrinologists meeting and at the European Congress on Obesity, investigators presented a one year study on its usefulness in treating obesity for people who do not […]

New standards for food labeling will emerge from the FDA sometime next month. This will be the first change since the nutrition facts label format was introduced 21 years ago. But before that can happen, the White House Office of Management and Budget must review them. Does that help your confidence that an evidence-based proposal […]

Yet another new diabetes drug — dapagliflozin, branded as Farxiga — in a class of drugs with helpful effects on weight received final FDA approval on Wednesday. The drug is the product of a joint venture in diabetes by AstraZeneca and Bristol-Meyers Squibb, soon to be wholly owned by AstraZeneca. Dapagliflozin joins canagliflozin (Invokana) in a new […]

Bogus weight loss products and other dietary supplements — unfettered by regulatory approval for safety and efficacy — have been linked to a spike in liver injuries. And more trouble lies ahead for dietary supplement makers. On Tuesday the Federal Trade Commission (FTC) will unveil a new effort to shut down deceptive advertising for bogus […]